A groundbreaking new therapy is offering a glimmer of hope for individuals living with HIV. Researchers are exploring CAR-T therapy, a revolutionary approach that could potentially offer a functional cure for a much wider patient population than previous methods. Unlike earlier treatments that involved complex procedures like bone marrow transplants from donors with specific genetic mutations, CAR-T therapy is a one-time treatment that involves modifying a patient’s own immune cells.
The CAR-T therapy works by extracting a patient’s T-cells, which are then genetically altered in a laboratory to target and attack HIV. These modified cells are then multiplied and infused back into the patient’s body. In this specific Phase 1 trial, the CAR-T therapy was designed to target key components of the HIV virus, specifically the CD4 and CCR5 binding sites, which are crucial for the virus to infect cells.
Early results from the trial have been highly encouraging. Of the three patients who received a standard dose of the CAR-T therapy, two have managed to maintain undetectable or very low levels of HIV in their bodies even after discontinuing their antiretroviral therapy (ART). One of these patients has been off HIV medication for over two years and continues to do well, while the other has maintained this status for nearly a year.
Dr. Steven Deeks, a professor of medicine at the University of California, San Francisco, and the lead investigator of the study, highlighted the importance of early diagnosis and prompt treatment in achieving these positive outcomes. He noted that the patients who have remained off HIV drugs for the longest periods and are experiencing success were diagnosed and put on therapy relatively quickly.
CAR-T therapy is not entirely new to the medical field; it is currently an established treatment for several types of blood cancers. Its potential is also being investigated for autoimmune diseases like lupus and scleroderma, demonstrating its versatility and growing application in various medical conditions.
This advancement in CAR-T therapy represents a significant step forward in the ongoing fight against HIV, offering the possibility of a more accessible and potentially curative treatment option for many. Further research and clinical trials are expected to build upon these promising initial findings.
Source: Medscape
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
car t hiv cure cell therapy for does kill cells how destroy can be cured completely long treatment last anti cart target what to expect after why helper and process in pioneering advances navigating challenges card test price principle against aids opportunities immunotherapy developing cd4 infect gene cost clinical trials crispr 2025 genetic editing deactivated vector american guidelines ccr5 could disease new infection icd 10 on drugs near me injection pregnant women medication options regimens as prevention art algorithm exposure adherence access azt aafp prognosis breakthrough backbone bengali brands bnf by bc best hospital india bangalore before 24 hours center clinic with insurance cdc cascade usa classes during pregnancy drug name crossword duration clue date development doctor effectiveness evolution expensive examples every 6 months early stage explained egypt 3 men florida newborn first line facilities children failure definition free goals pdf gilead idsa 2026 zambia history haart timeline pills hub hindi quezon city mexico the 90s infants chronic kidney honduras thailand prison japan jab journal jamaica johor bahru journey medicine impact factor juluca care jobs kannada kit kenya kya hai kolkata kerala kuwait knowledge scale korea kids life expectancy latest news lenacapavir lines acting literacy you live meds names malaysia methods malta monitoring mechanism no nih now nnrti update nz nhs overview one pill a day or online not odefsey plan protocol pictures paradigm pipeline qatar quora quotes questions quizlet quiz quartile qld research resistance restrictions recommendations regimen regime reddit release shot side effects skin success rate states satisfaction questionnaire stem statistics symptoms scholarly articles today twice year truvada training tamil tablets time tld uptodate uk uganda using usmle vaccine viral load vs prep video vancouver victoria vietnam venezuela viiv wiki while without who window tb works within 72 youtube yes yearly yet yeztugo zidovudine zimbabwe zero finals z